TipRanks
Advertisement
Advertisement

PRTA Stock Latest News

Analyst Reiterates Buy on Prothena, Citing Disciplined Capital Strategy and Undervalued TTR Franchise with Unchanged $30 Price Target
RatingsAnalyst Reiterates Buy on Prothena, Citing Disciplined Capital Strategy and Undervalued TTR Franchise with Unchanged $30 Price Target
2M ago
PRTA
Prothena reports Q2 EPS (36c), consensus (39c)
PremiumThe Fly
Prothena reports Q2 EPS (36c), consensus (39c)
2M ago
PRTA
Is PRTA a Buy, Before Earnings?
PremiumPre-Earnings
Is PRTA a Buy, Before Earnings?
2M ago
PRTA
Analyst Reiterates Buy on Prothena, Maintains $30 Price Target on Differentiated TTR-Depleter Opportunity
PremiumRatings
Analyst Reiterates Buy on Prothena, Maintains $30 Price Target on Differentiated TTR-Depleter Opportunity
2M ago
PRTA
3 Stocks Flashing Positive Insider Buying Signals
PremiumMarket News
3 Stocks Flashing Positive Insider Buying Signals
4M ago
PEB
PRTA
Prothena Shareholders Reaffirm Board, Auditor and Pay Policies
PremiumCompany AnnouncementsProthena Shareholders Reaffirm Board, Auditor and Pay Policies
5M ago
8K
PRTA
Biogen CELIA topline readout in Alzheimer’s ‘historic,’ says H.C. Wainwright
Premium
The Fly
Biogen CELIA topline readout in Alzheimer’s ‘historic,’ says H.C. Wainwright
5M ago
DYN
ALEC
Analyst Reiterates Buy on Prothena, Maintaining $30 Price Target on CYTOPE and PRX012-TfR Platform Strength
Premium
Ratings
Analyst Reiterates Buy on Prothena, Maintaining $30 Price Target on CYTOPE and PRX012-TfR Platform Strength
5M ago
PRTA
Prothena price target raised to $20 from $19 at Citizens
PremiumThe Fly
Prothena price target raised to $20 from $19 at Citizens
5M ago
PRTA
Prothena reports Q1 EPS 60c vs ($1.12) last year
PremiumThe Fly
Prothena reports Q1 EPS 60c vs ($1.12) last year
5M ago
PRTA
Prothena cuts FY26 net cash used view to $18M-$23M from $50M-$55M
PremiumThe Fly
Prothena cuts FY26 net cash used view to $18M-$23M from $50M-$55M
5M ago
PRTA
Prothena Corporation (PRTA) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
Prothena Corporation (PRTA) Q1 Earnings Cheat Sheet
5M ago
PRTA
Prothena announces Novo Nordisk obtained FDA fast track for PRX004
PremiumThe FlyProthena announces Novo Nordisk obtained FDA fast track for PRX004
5M ago
NVO
PRTA
Prothena names Annie Kingston as Chief Strategy Officer
Premium
The Fly
Prothena names Annie Kingston as Chief Strategy Officer
6M ago
PRTA
Prothena (PRTA): Partner-Funded, Milestone-Rich Pipeline De-Risks Lead Programs and Supports Buy Rating
Premium
Ratings
Prothena (PRTA): Partner-Funded, Milestone-Rich Pipeline De-Risks Lead Programs and Supports Buy Rating
7M ago
PRTA
Prothena achieves $50M clinical milestone payment from Novo Nordisk
PremiumThe Fly
Prothena achieves $50M clinical milestone payment from Novo Nordisk
7M ago
NVO
PRTA
Prothena Announces $100 Million Share Repurchase Program
PremiumCompany Announcements
Prothena Announces $100 Million Share Repurchase Program
7M ago
8K
PRTA
Prothena announces $100M share repurchase plan
PremiumThe Fly
Prothena announces $100M share repurchase plan
7M ago
PRTA
Prothena expects to end year with $255M in cash, equivalents
PremiumThe Fly
Prothena expects to end year with $255M in cash, equivalents
7M ago
BMY
NVO
Prothena Earnings Call: Pipeline Progress, Risks Ahead
PremiumCompany AnnouncementsProthena Earnings Call: Pipeline Progress, Risks Ahead
7M ago
PRTA
Prothena: Transformative CYTOPE and TfR Platforms Underpin Long‑Term Upside and Support Buy Rating
Premium
Ratings
Prothena: Transformative CYTOPE and TfR Platforms Underpin Long‑Term Upside and Support Buy Rating
7M ago
PRTA
Prothena reports Q4 EPS (40c), consensus (46c)
Premium
The Fly
Prothena reports Q4 EPS (40c), consensus (46c)
7M ago
PRTA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >